I am currently looking for a good entry point here. Technology seems promising and there are several near-term catalysts. Market Cap is around $23 Million. ENDRA Life Sciences' mission is to bring new capabilities to ultrasound and broaden access to better healthcare. ENDRA is developing a next generation Thermo-Acoustic Enhanced UltraSound (TAEUS™) system to enable clinicians to visualize human tissue composition, function and temperature in ways previously possible only with CT & MRI -- at a fraction of the cost, and at the point-of-care. ENDRA's first TAEUS application will focus on the quantification of fat in the liver, for early detection and monitoring of Non-Alcoholic Fatty Liver Disease, which affects over 1 billion people globally. August 24, 2020 ENDRA Life Sciences to Receive $5 Million From Early Warrant Exercises http://investors.endrainc.com/prviewer/release_only/id/4431725 "More importantly, the proceeds should extend our cash runway through key business inflection points, including establishing evaluation reference sites and initial sales in Europe, as well as the potential receipt of FDA clearance to begin commercialization in the U.S. this year." Excerpts Investor Presentation http://investors.endrainc.com/
